Biotech Unusual Volume: Evogene (NYSE:EVGN), Heat Biologics Inc (NASDAQ:HTBX), Alseres Pharmaceuticals (OTCMKTS:ALSE), EntreMed (NASDAQ:ENMD)

Evogene Ltd. (NYSE:EVGN)(TASE:EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, announced today its financial results for the fourth quarter and year ended December 31, 2013. Evogene Ltd (NYSE:EVGN) stock performance was 2.35% in last session and finished the day at $19.56. Traded volume was 54,493 million shares in the last session and the average volume … Continue reading Biotech Unusual Volume: Evogene (NYSE:EVGN), Heat Biologics Inc (NASDAQ:HTBX), Alseres Pharmaceuticals (OTCMKTS:ALSE), EntreMed (NASDAQ:ENMD)

Colin Pettis03/2103/21

Biotech Unusual Volume: Tengion (OTCMKTS:TNGN), Alseres Pharmaceuticals (OTCMKTS:ALSE), Fate Therapeutics (NASDAQ:FATE), Synthetic Biologics (NYSEMKT:SYN)

Tengion, Inc. (OTCMKTS:TNGN) on Mar. 3 issued notices to the holders (the “2012 Investors”) of senior secured notes issued on October 2, 2012 and to the holders (the “2013 Investors” and together with the 2012 Investors, the “Investors” and each, an “Investor”) of senior secured notes issued on June 28, 2013 stating that the Company plans to issue shares of common stock, $0.001 par value … Continue reading Biotech Unusual Volume: Tengion (OTCMKTS:TNGN), Alseres Pharmaceuticals (OTCMKTS:ALSE), Fate Therapeutics (NASDAQ:FATE), Synthetic Biologics (NYSEMKT:SYN)

Colin Pettis03/1703/17